Med247 is a technology company.
Med247 has raised $5.0M across 1 funding round.
Med247 has raised $5.0M in total across 1 funding round.
Med247 has raised $5.0M in total across 1 funding round.
Med247's investors include Auspac Investment Management, KK Fund.
Med247 is a Vietnamese health tech startup founded in 2019 that operates a hybrid offline-to-online (O2O) digital healthcare platform, combining telemedicine consultations, online prescriptions, health monitoring via AI-powered tools, and a network of family clinics for primary and preventive care.[1][2][3][4] It serves underserved patients in Vietnam by providing 24/7 access to multi-specialty services through its mobile app, where users book appointments, access remote video/chat consultations, request electronic medical records, order delivered medicines/tests, and screen vital signs using smartphone camera-based PPG technology and AI.[2][3] The platform addresses gaps in primary family care by integrating convenient chain clinics with virtual services, aiming to be a one-stop shop for pharmaceuticals, clinical support, and telemedicine, with recent $4.5M Series A funding fueling expansion to over 70 clinics, a training academy, and R&D acceleration.[2][3]
Med247 was co-founded in 2019 by CEO Tuan Truong and COO Thao Nguyen, launching with seed funding from KK Fund to pioneer an O2O model in Vietnam's healthcare sector.[2] The idea emerged from a vision to reinvent virtual healthcare and boost access for underserved primary care patients, blending offline family clinics (starting with just four) with online telehealth amid rising demand for convenient, tech-enabled services in a market with limited options.[2] Early traction came from its mobile app's innovative features like AI vital sign screening, leading to an oversubscribed $4.5M Series A in 2022 led by Altara Ventures, with participation from Pavilion Capital, MiRXES, East Ventures, and Venturra Ventures—marking a pivotal shift from startup to scaled operator.[2][3]
Med247 rides Vietnam's booming digital health wave, fueled by smartphone penetration, post-pandemic telehealth adoption, and government pushes for accessible primary care in underserved areas.[2] Its timing aligns with regional trends like online pharmacies (e.g., Medigo's $1M raise) and O2O models addressing fragmented healthcare, where urban-rural divides limit clinic access.[2] Market forces favoring it include Vietnam's young population, rising health awareness, and investor interest in scalable health tech—evidenced by oversubscribed funding amid economic growth.[2][3] By building clinics, training providers, and advancing AI tools, Med247 influences the ecosystem by standardizing family care, reducing hospital overload, and inspiring hybrid models across Southeast Asia.[2][5]
Med247's momentum positions it for dominance in Vietnam's primary care market, with clinic scaling to 70+, academy launches, and AI enhancements driving user growth and retention.[2] Trends like AI diagnostics, regulatory telemedicine support, and regional health tech investments will shape its path, potentially expanding cross-border or into specialties.[2] Its influence may evolve from local innovator to ecosystem leader, blending physical networks with digital scale to redefine accessible care—echoing its founding mission to serve the underserved at any time, anywhere.[2]
Med247 has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Series A in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2022 | $5.0M Series A | Auspac Investment Management, KK Fund |